Why the study?
Are lipoprotein lipase gene variants associated with an altered risk of cardiovascular disease?
Are lipoprotein lipase gene variants associated with an altered risk of cardiovascular disease?
Lipoprotein lipase gene variants are associated with differential susceptibility to cardiovascular disease, with some variants increasing risk and others being cardioprotective.
No takes yet. Share an insight, caveat, or question.
LPL variants may refine genetic CVD risk prediction; leaves open effects on therapy or outcomes.
John E. Hokanson (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: